Literature DB >> 6724622

Selective elimination of fibroblasts from cultures of normal human melanocytes.

R Halaban, F D Alfano.   

Abstract

The main obstacle to establishing pure normal human melanocytes in vitro is contamination of the cultures by fibroblasts. The obstacle can be overcome by selective destruction of fibroblasts with geneticin ( G418 sulfate). Treatment of mixed cultures with this drug at a concentration of 100 micrograms/ml for two days results in pure cultures of normal human melanocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724622     DOI: 10.1007/BF02619590

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  3 in total

1.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

2.  Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin.

Authors:  M Eisinger; O Marko
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

3.  Regulation of tyrosinase in human melanocytes grown in culture.

Authors:  R Halaban; S H Pomerantz; S Marshall; D T Lambert; A B Lerner
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

  3 in total
  47 in total

1.  PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

Authors:  I C Le Poole; R E Boissy; R Sarangarajan; J Chen; J J Forristal; P Sheth; W Westerhof; G Babcock; P K Das; C B Saelinger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

Review 2.  Aminoglycosides: activity and resistance.

Authors:  M P Mingeot-Leclercq; Y Glupczynski; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 3.  Aminoglycoside antibiotics: structure, functions and effects on in vitro plant culture and genetic transformation protocols.

Authors:  I M G Padilla; L Burgos
Journal:  Plant Cell Rep       Date:  2010-07-20       Impact factor: 4.570

4.  Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.

Authors:  B S Kwon; A K Haq; S H Pomerantz; R Halaban
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Membranous complexes characteristic of melanocytes derived from patients with Hermansky-Pudlak syndrome type 1 are macroautophagosomal entities of the lysosomal compartment.

Authors:  Justin W Smith; Amy Koshoffer; Randal E Morris; Raymond E Boissy
Journal:  Pigment Cell Res       Date:  2005-12

6.  Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis.

Authors:  H R Byers; T Etoh; J R Doherty; A J Sober; M C Mihm
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

7.  New procedure for epidermal cell isolation using kiwi fruit actinidin, and improved culture of melanocytes in the presence of leukaemia inhibitory factor and forskolin.

Authors:  Reza Yarani; Kamran Mansouri; Hamid Reza Mohammadi-Motlagh; Mitra Bakhtiari; Ali Mostafaie
Journal:  Cell Prolif       Date:  2013-05-10       Impact factor: 6.831

8.  Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2.

Authors:  Tal Varsano; Eric Lau; Yongmei Feng; Marine Garrido; Loribelle Milan; Susanne Heynen-Genel; Christian A Hassig; Ze'ev A Ronai
Journal:  Clin Cancer Res       Date:  2013-04-15       Impact factor: 12.531

9.  Normal murine melanocytes in culture.

Authors:  A Tamura; R Halaban; G Moellmann; J M Cowan; M R Lerner; A B Lerner
Journal:  In Vitro Cell Dev Biol       Date:  1987-07

10.  Isolation, establishment, and characterization of ex vivo equine melanoma cell cultures.

Authors:  Sarah W Kamau Chapman; Nadine Metzger; Paula Grest; Karsten Feige; Brigitte von Rechenberg; Jörg A Auer; Michael O Hottiger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-12-05       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.